SCHEMBL28952012

SCHEMBL28952012

c1ccc(COc2cccc(C[C]3CC3)c2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 4/20 0.58
▸ CYP4F2 P78329 1/20 0.58
▸ CYP4A11 Q02928 1/20 0.58
▸ MAOB P27338 5/20 0.57
▸ MAOA P21397 1/20 0.53
▸ NR4A2 P43354 1/20 0.53
▸ DHFR P00374 1/20 0.52
▸ ALOX5 P09917 1/20 0.51
▸ DPYD Q12882 1/20 0.51
▸ KDM4E B2RXH2 1/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ GAA P10253 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ THRB P10828 1/20 0.50
▸ PKM P14618 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ BLM P54132 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15761340 0.81 BCHE (0.70) BCHECYP4F2CYP4A11MAOBMAOA
SCHEMBL1268719 0.81 MAOB (0.81) BCHECYP4F2CYP4A11MAOBMAOA
SCHEMBL5329319 0.80 MAOB (0.72) BCHECYP4F2CYP4A11MAOBMAOA
SCHEMBL19389796 0.77 HPD (0.51) BCHECYP4F2CYP4A11MAOBMAOA
SCHEMBL5546051 0.77 BCHE (0.64) BCHECYP4F2CYP4A11MAOBMAOA
SCHEMBL80829 0.77 MAOB (0.68) BCHECYP4F2CYP4A11MAOBMAOA
SCHEMBL1351689 0.77 BCHE (0.64) BCHECYP4F2CYP4A11MAOBMAOA
SCHEMBL80163 0.77 CYP4F2 (0.74) BCHECYP4F2CYP4A11MAOBMAOA
SCHEMBL91188 0.77 MAOB (0.68) BCHECYP4F2CYP4A11MAOBMAOA
SCHEMBL538599 0.77 MAOB (0.70) BCHECYP4F2CYP4A11MAOBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115698035-A Inhibitors of norovirus and coronavirus replication 共晶制药公司 2023-02-03 — — CN disclosed
Send feedback